首页> 外文期刊>Molecular genetics and metabolism >A practical fluorometric assay method to measure lysosomal acid lipase activity in dried blood spots for the screening of cholesteryl ester storage disease and Wolman disease
【24h】

A practical fluorometric assay method to measure lysosomal acid lipase activity in dried blood spots for the screening of cholesteryl ester storage disease and Wolman disease

机译:一种实用的荧光测定法,用于测量干血斑中的溶酶体酸脂肪酶活性,用于筛选胆固醇酯贮积病和沃尔曼病

获取原文
获取原文并翻译 | 示例
           

摘要

Fluorometric measurements of 4-methylumbelliferone (4-MU) are generally used to screen lysosomal storage diseases (LSDs) using dried blood spots (DBSs). However, in DBS, it is difficult to measure lysosomal acid lipase (LAL) activity due to the influence of other lipases in whole blood. Recently, Hamilton used a fluorometric enzyme assay with 4-MU derivatives to measure the LAL activity in DBS. This method requires mercury chloride as stopping reagent, and the fluorescence intensity of 4-MU was measured at an acidic pH. We report a revised method to measure the LAL activity without using toxic mercury chloride and to measure the fluorescence intensity of 4-MU at a basic pH. For this measurement, we established a more practical method that does not require mercury chloride. The LAL activity in DBS was measured in 51 normal controls, seven obligate carriers and seven patients with CESD. The average LAL activities ± SD in the DBS from the normal, obligate carriers and CESD patients were 0.68 ± 0.2 (range: 0.3-1.08), 0.21 ± 0.1 (range: 0.11-0.41) and 0.02 ± 0.02 (range: 0-0.06) nmol/punch/h, respectively. There was a significant difference between the normal and the CESD. Our method does not require toxic mercury chloride and is an appropriate revised enzyme assay using DBS for screening patients with CESD.
机译:通常使用4-甲基伞形酮(4-MU)进行荧光测定,以使用干血斑(DBS)筛选溶酶体贮积病(LSD)。但是,在DBS中,由于全血中其他脂肪酶的影响,很难测量溶酶体酸性脂肪酶(LAL)的活性。最近,汉密尔顿使用含4-MU衍生物的荧光酶测定法来测量DBS中的LAL活性。该方法需要氯化汞作为终止剂,并且在酸性pH下测量4-MU的荧光强度。我们报告了一种修订的方法,可以在不使用有毒氯化汞的情况下测量LAL活性,并在碱性pH下测量4-MU的荧光强度。对于此测量,我们建立了一种不需要氯化汞的更实用的方法。在51名正常对照,7名专职携带者和7名CESD患者中测量了DBS中的LAL活性。正常,专心携带者和CESD患者的DBS的平均LAL活性±SD为0.68±0.2(范围:0.3-1.08),0.21±0.1(范围:0.11-0.41)和0.02±0.02(范围:0-0.06) )nmol / punch / h。正常人与CESD之间存在显着差异。我们的方法不需要有毒的氯化汞,它是使用DBS进行筛查CESD患者的一种适当的改良酶法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号